Cargando…

Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation

This study aims to determine the predictive value of the soluble suppression of tumorigenicity 2 (sST2) biomarker in atrial fibrillation (AF) recurrence. This prospective, observational study included patients with AF referred for electrical cardioversion (ECV) or pulmonary vein isolation (PVI) proc...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Seara, Javier, González Melchor, Laila, Rodríguez García, Javier, Gude, Francisco, Martínez Sande, José Luis, Rodríguez Mañero, Moisés, Fernández López, Xesús Alberte, Minguito Carazo, Carlos, González Ferrero, Teba, Eiras, Sonia, Lage, Ricardo, Moscoso, Isabel, Bandín, Sandra Feijoo, Lago, Francisca, Alvarez, Ezequiel, Alvarez, Clara V., González Juanatey, José Ramón
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531224/ https://www.ncbi.nlm.nih.gov/pubmed/37762349 http://dx.doi.org/10.3390/ijms241814045

Ejemplares similares

Is HATCH score a reliable predictor of atrial fibrillation after cavotricuspid isthmus ablation for typical atrial flutter?
por: García-Seara, Javier, et al.
Publicado: (2016)

Radiofrequency ablation of an atypical left accessory pathway from the left coronary cusp
por: Martinez-Sande, Jose Luis, et al.
Publicado: (2020)

Leadless pacemaker implantation with hybrid image mapping technique in a congenital heart disease case
por: Martinez-Sande, Jose Luis, et al.
Publicado: (2021)

Conventional single-chamber pacemakers versus transcatheter pacing systems in a “real world” cohort of patients: A comparative prospective single-center study
por: Martinez-Sande, Jose Luis, et al.
Publicado: (2021)

Changes in autonomic response during cardioneuroablation in an elderly patient with carotid sinus syndrome
por: Minguito-Carazo, Carlos, et al.
Publicado: (2022)

Long‐term cardiac reverse remodeling after cardiac resynchronization therapy
por: Alvarez‐Alvarez, Belén, et al.
Publicado: (2021)

Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation
por: Lage, Ricardo, et al.
Publicado: (2023)

Assessment of long-term quality of life after cavotricuspid isthmus ablation for typical atrial flutter
por: Cabanas-Grandío, Pilar, et al.
Publicado: (2014)

Circulating miR-499a and miR-125b as Potential Predictors of Left Ventricular Ejection Fraction Improvement after Cardiac Resynchronization Therapy
por: Moscoso, Isabel, et al.
Publicado: (2022)

Atrial fibrillation ablation in patients with arrhythmia‐induced cardiomyopathy: a prospective multicentre study
por: González‐Ferrero, Teba, et al.
Publicado: (2023)

Utility of ST2 soluble biomarker in patients with atrial fibrillation and pulmonary veins isolation
por: Gonzalez-Melchor, L, et al.
Publicado: (2023)

Cardioneuroablation for the treatment of vasovagal syncope, functional sinus node dysfunction and functional atrioventricular block: initial experience in one center
por: Minguito Carazo, C, et al.
Publicado: (2023)

Prognostic value of nutrition status in the response of cardiac resynchronization therapy
por: Alvarez-Alvarez, Belén, et al.
Publicado: (2018)

Cardiac resynchronization therapy outcomes in patients under nonoptimal medical therapy
por: Alvarez‐Alvarez, Belén, et al.
Publicado: (2018)

Neuromodulatory Approaches for Atrial Fibrillation Ablation
por: Rodríguez-Mañero, Moisés, et al.
Publicado: (2021)

Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers
por: Aragón-Herrera, Alana, et al.
Publicado: (2022)

The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation
por: López-Canoa, José Nicolás, et al.
Publicado: (2022)

Initial experience and treatment of atrial fibrillation using a novel irrigated multielectrode catheter: Results from a prospective two-center study
por: Rodríguez-Entem, Felipe, et al.
Publicado: (2016)

Ablation of atrial fibrillation in patients with Brugada syndrome: A systematic review of the literature
por: Rodríguez‐Mañero, Moisés, et al.
Publicado: (2018)

Epicardial mapping and ablation of the right ventricle substrate during flecainide testing in Brugada syndrome
por: Gonzalez-Melchor, Laila, et al.
Publicado: (2015)

Selección de lo mejor del año 2020 en arritmias cardiacas
por: García Seara, Javier, et al.
Publicado: (2021)

Ethanol infusion in the vein of Marshall: A potential bail-out strategy in cardioneuromodulation procedures?
por: Rodríguez-Mañero, Moisés, et al.
Publicado: (2022)

Comparison between CHA(2)DS(2)-VASc and the new R(2)CHADS(2) and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation
por: Abumuaileq, Rami Riziq-Yousef, et al.
Publicado: (2015)

High-density open window mapping vs conventional mapping in accessory pathways ablation
por: Martinez-Sande, J L, et al.
Publicado: (2023)

Plasma miR-486-5p Expression Is Upregulated in Atrial Fibrillation Patients with Broader Low-Voltage Areas
por: Cebro-Márquez, María, et al.
Publicado: (2023)

Health-related quality of life in different clinical subgroups with typical AFL who have undergone cavo-tricuspid isthmus ablation
por: García Seara, Javier, et al.
Publicado: (2012)

Omentin protects H9c2 cells against docetaxel cardiotoxicity
por: Lage, Ricardo, et al.
Publicado: (2019)

Relaxin-2 in Cardiometabolic Diseases: Mechanisms of Action and Future Perspectives
por: Feijóo-Bandín, Sandra, et al.
Publicado: (2017)

Adipokines and Inflammation: Focus on Cardiovascular Diseases
por: Feijóo-Bandín, Sandra, et al.
Publicado: (2020)

Regarding ‘Clinical controversy: methodology and indications of cardioneuroablation for reflex syncope’
por: Martínez-Alday, Jesús Daniel, et al.
Publicado: (2023)

COVID-19 y tratamiento guiado con tests de diagnóstico bioquímicos y moleculares para reducir el daño cardiaco y la cardiotoxicidad
por: Eiras, Sonia, et al.
Publicado: (2020)

COVID-19 and treatment guided by biochemical and molecular diagnostic tests to reduce myocardial damage and cardiotoxicity
por: Eiras, Sonia, et al.
Publicado: (2020)

A case report of arterial and venous thromboembolism in a patient with severe COVID-19 pneumonia
por: Del Castillo-García, Samuel, et al.
Publicado: (2020)

The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure
por: Fu, Xiaoran, et al.
Publicado: (2022)

The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile
por: Aragón-Herrera, Alana, et al.
Publicado: (2022)

Inflammatory and lipid regulation by cholinergic activity in epicardial stromal cells from patients who underwent open‐heart surgery
por: Couselo‐Seijas, Marinela, et al.
Publicado: (2020)

A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population
por: Rodríguez-Mañero, Moisés, et al.
Publicado: (2019)

Diabesity in Elderly Cardiovascular Disease Patients: Mechanisms and Regulators
por: García-Vega, David, et al.
Publicado: (2022)

Circulating mitochondrial genes detect acute cardiac allograft rejection: Role of the mitochondrial calcium uniporter complex
por: Tarazón, Estefanía, et al.
Publicado: (2020)

Increased Expression of Fatty-Acid and Calcium Metabolism Genes in Failing Human Heart
por: García-Rúa, Vanessa, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4gsvkgbosjis79c9q26g8q2m9h